Factors related to outcome of early and delayed prosthetic joint infections.
Service of Infectious Diseases, Geneva University Hospitals & Faculty of Medicine, University of Geneva, Switzerland.
Diem-Lan
DL
Vu
Service of Infectious Diseases, Geneva University Hospitals & Faculty of Medicine, University of Geneva, Switzerland; Orthopaedic Surgery Service, Geneva University Hospitals & Faculty of Medicine, University of Geneva, Switzerland. Electronic address: ilker.uckay@hcuge.ch.
Ilker
I
Uçkay
Orthopaedic Surgery Service, Geneva University Hospitals & Faculty of Medicine, University of Geneva, Switzerland.
Amanda
A
Gonzalez
Coding Office, Geneva University Hospitals & Faculty of Medicine, University of Geneva, Switzerland.
Peter
P
Rohner
Orthopaedic Surgery Service, Geneva University Hospitals & Faculty of Medicine, University of Geneva, Switzerland.
Pierre
P
Hoffmeyer
Orthopaedic Surgery Service, Geneva University Hospitals & Faculty of Medicine, University of Geneva, Switzerland.
Anne
A
Lübbeke
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003428:Cross Infection / Q000382:microbiology*; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000628:therapy*; D016908:Gram-Positive Bacterial Infections / Q000628:therapy*; D006801:Humans; D007595:Joint Prosthesis / Q000009:adverse effects*; D008297:Male; D016459:Prosthesis-Related Infections / Q000628:therapy*
D000900:Anti-Bacterial Agents
Epidemiology; Haematogenous; Hip arthroplasty; Knee arthroplasty; Prosthetic joint infection